Form 4: Emmaus Life Sciences Director Lim Seah H. Acquires 20,000 Shares

Director Lim Seah H. of Emmaus Life Sciences, Inc. reports purchasing 20,000 shares of common stock at $0.04 per share on September 16, 2024.

Summary

• On September 16, 2024, Lim Seah H., a director of Emmaus Life Sciences, Inc., acquired 20,000 shares of common stock.
• The purchase price was $0.04 per share.
• Following the transaction, Lim Seah H. directly owns 4,606,626 shares of Emmaus Life Sciences, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares can be seen as a vote of confidence, but the quantity is relatively small and the price is low.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders of a company (officers, directors, or those holding more than 10% of the company's shares) buy or sell the company's securities. These filings provide transparency to the market regarding insider transactions.

Stakeholder Impact

• The purchase could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Form 4, Beneficial Ownership, Emmaus Life Sciences, Director, Stock Acquisition, Lim Seah H., EMMA